{"id":16328,"date":"2026-05-21T12:14:35","date_gmt":"2026-05-21T06:44:35","guid":{"rendered":"https:\/\/www.torusdigital.com\/toruscope\/?p=16328"},"modified":"2026-05-21T12:15:27","modified_gmt":"2026-05-21T06:45:27","slug":"q-line-biotech-ipo-opens-key-details-investors-shouldnt-miss","status":"publish","type":"post","link":"https:\/\/www.torusdigital.com\/toruscope\/news\/q-line-biotech-ipo-opens-key-details-investors-shouldnt-miss\/","title":{"rendered":"Q-Line Biotech IPO Opens: Key Details Investors Shouldn\u2019t Miss"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_section el_id=&#8221;blog-inner-layout&#8221;][vc_row overlay_dotted=&#8221;&#8221;][vc_column el_class=&#8221;blog_primary&#8221;][vc_row_inner][vc_column_inner][vc_column_text css=&#8221;&#8221;]<\/p>\n<div class=\"flex flex-col text-sm pb-25\">\n<article class=\"text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [&amp;:has([data-writing-block])&gt;*]:pointer-events-auto scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]\" dir=\"auto\" tabindex=\"-1\" data-turn-id=\"2d704d44-fd64-42c6-bcdc-2f43628167d3\" data-testid=\"conversation-turn-16\" data-scroll-anchor=\"true\" data-turn=\"assistant\">\n<div class=\"text-base my-auto mx-auto pb-10 [--thread-content-margin:--spacing(4)] @w-sm\/main:[--thread-content-margin:--spacing(6)] @w-lg\/main:[--thread-content-margin:--spacing(16)] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group\/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn\" tabindex=\"-1\">\n<div class=\"flex max-w-full flex-col grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&amp;]:mt-1\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"629c3ed0-f800-4c13-a884-fae5f620656d\" data-message-model-slug=\"gpt-5-2-thinking\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[1px]\">\n<div class=\"markdown prose dark:prose-invert w-full wrap-break-word light markdown-new-styling\">\n<div class=\"flex flex-col text-sm pb-25\">\n<article class=\"text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [&amp;:has([data-writing-block])&gt;*]:pointer-events-auto scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]\" dir=\"auto\" tabindex=\"-1\" data-turn-id=\"request-6983268a-f9d0-83a3-a8d3-6d3ee62149e4-0\" data-testid=\"conversation-turn-18\" data-scroll-anchor=\"true\" data-turn=\"assistant\">\n<div class=\"text-base my-auto mx-auto pb-10 [--thread-content-margin:--spacing(4)] @w-sm\/main:[--thread-content-margin:--spacing(6)] @w-lg\/main:[--thread-content-margin:--spacing(16)] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group\/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn\" tabindex=\"-1\">\n<div class=\"flex max-w-full flex-col grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&amp;]:mt-1\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"2e1eba92-cc1e-4335-ad7e-eac92a73e54d\" data-message-model-slug=\"gpt-5-2-thinking\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[1px]\">\n<div class=\"markdown prose dark:prose-invert w-full wrap-break-word light markdown-new-styling\">\n<div class=\"flex flex-col text-sm pb-25\">\n<article class=\"text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [&amp;:has([data-writing-block])&gt;*]:pointer-events-auto scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]\" dir=\"auto\" tabindex=\"-1\" data-turn-id=\"request-6983268a-f9d0-83a3-a8d3-6d3ee62149e4-0\" data-testid=\"conversation-turn-22\" data-scroll-anchor=\"true\" data-turn=\"assistant\">\n<div class=\"text-base my-auto mx-auto pb-10 [--thread-content-margin:--spacing(4)] @w-sm\/main:[--thread-content-margin:--spacing(6)] @w-lg\/main:[--thread-content-margin:--spacing(16)] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group\/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn\" tabindex=\"-1\">\n<div class=\"flex max-w-full flex-col grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&amp;]:mt-1\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"0537bf50-da28-4255-a8d0-f38a39fdb264\" data-message-model-slug=\"gpt-5-2\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[1px]\">\n<div class=\"markdown prose dark:prose-invert w-full wrap-break-word light markdown-new-styling\">\n<div class=\"text-base my-auto mx-auto [--thread-content-margin:--spacing(4)] @w-sm\/main:[--thread-content-margin:--spacing(6)] @w-lg\/main:[--thread-content-margin:--spacing(16)] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group\/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn\" tabindex=\"-1\">\n<div class=\"flex max-w-full flex-col grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&amp;]:mt-1\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"0537bf50-da28-4255-a8d0-f38a39fdb264\" data-message-model-slug=\"gpt-5-2\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[1px]\">\n<div class=\"markdown prose dark:prose-invert w-full wrap-break-word light markdown-new-styling\">\n<div class=\"flex max-w-full flex-col grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&amp;]:mt-1\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"a9eb94cf-6376-4f55-be55-c60a4d35d0be\" data-message-model-slug=\"gpt-5-3\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[1px]\">\n<div class=\"markdown prose dark:prose-invert w-full wrap-break-word light markdown-new-styling\">\n<section class=\"text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [&amp;:has([data-writing-block])&gt;*]:pointer-events-auto [content-visibility:auto] supports-[content-visibility:auto]:[contain-intrinsic-size:auto_100lvh] R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]\" dir=\"auto\" data-turn-id=\"request-WEB:5737049e-b444-4dc7-9a08-411852c4713a-1\" data-testid=\"conversation-turn-2\" data-scroll-anchor=\"false\" data-turn=\"assistant\">\n<div class=\"text-base my-auto mx-auto pb-10 [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm\/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg\/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group\/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"flex max-w-full flex-col gap-4 grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+&amp;]:mt-1\" dir=\"auto\" tabindex=\"0\" data-message-author-role=\"assistant\" data-message-id=\"3fcd7cdd-2e98-4a92-a4fe-6c9a47b59e7c\" data-turn-start-message=\"true\" data-message-model-slug=\"gpt-5-5-thinking\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden\">\n<div class=\"markdown prose dark:prose-invert wrap-break-word w-full light markdown-new-styling\">\n<div class=\"relative w-full overflow-visible\">\n<section class=\"text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [&amp;:has([data-writing-block])&gt;*]:pointer-events-auto [content-visibility:auto] supports-[content-visibility:auto]:[contain-intrinsic-size:auto_100lvh] R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]\" dir=\"auto\" data-turn-id=\"request-6983268a-f9d0-83a3-a8d3-6d3ee62149e4-0\" data-turn-id-container=\"request-6983268a-f9d0-83a3-a8d3-6d3ee62149e4-0\" data-testid=\"conversation-turn-166\" data-scroll-anchor=\"false\" data-turn=\"assistant\">\n<div class=\"text-base my-auto mx-auto [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm\/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg\/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group\/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"flex max-w-full flex-col gap-4 grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+&amp;]:mt-1\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"756ddd44-b5f1-4721-944e-47ca1e9b368f\" data-message-model-slug=\"gpt-5-5\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden\">\n<div class=\"markdown prose dark:prose-invert wrap-break-word w-full dark markdown-new-styling\">\n<div class=\"text-base my-auto mx-auto [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm\/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg\/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group\/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"flex max-w-full flex-col gap-4 grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+&amp;]:mt-1\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"727f3628-1b73-4e27-bc97-1583f50d0fd8\" data-message-model-slug=\"gpt-5-5\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden\">\n<div class=\"markdown prose dark:prose-invert wrap-break-word w-full dark markdown-new-styling\">\n<div class=\"qMYqUG_convSearchResultHighlightRoot\">\n<div class=\"\" data-turn-id-container=\"request-6983268a-f9d0-83a3-a8d3-6d3ee62149e4-0\" data-is-intersecting=\"true\">\n<section class=\"text-token-text-primary w-full focus:outline-none has-data-writing-block:pointer-events-none [&amp;:has([data-writing-block])&gt;*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]\" dir=\"auto\" data-turn-id=\"request-6983268a-f9d0-83a3-a8d3-6d3ee62149e4-0\" data-turn-id-container=\"request-6983268a-f9d0-83a3-a8d3-6d3ee62149e4-0\" data-testid=\"conversation-turn-178\" data-scroll-anchor=\"false\" data-turn=\"assistant\">\n<div class=\"text-base my-auto mx-auto pb-10 [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm\/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg\/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group\/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"flex max-w-full flex-col gap-4 grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+&amp;]:mt-1\" dir=\"auto\" tabindex=\"0\" data-message-author-role=\"assistant\" data-message-id=\"f1121c54-a4f8-4025-9960-5a0f9e3fe777\" data-turn-start-message=\"true\" data-message-model-slug=\"gpt-5-5\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden\">\n<div class=\"markdown prose dark:prose-invert wrap-break-word w-full light markdown-new-styling\">\n<div class=\"qMYqUG_convSearchResultHighlightRoot\">\n<div class=\"\" data-turn-id-container=\"request-6983268a-f9d0-83a3-a8d3-6d3ee62149e4-2\" data-is-intersecting=\"true\">\n<section class=\"text-token-text-primary w-full focus:outline-none has-data-writing-block:pointer-events-none [&amp;:has([data-writing-block])&gt;*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]\" dir=\"auto\" data-turn-id=\"request-6983268a-f9d0-83a3-a8d3-6d3ee62149e4-2\" data-turn-id-container=\"request-6983268a-f9d0-83a3-a8d3-6d3ee62149e4-2\" data-testid=\"conversation-turn-182\" data-scroll-anchor=\"false\" data-turn=\"assistant\">\n<div class=\"text-base my-auto mx-auto pb-10 [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm\/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg\/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group\/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"flex max-w-full flex-col gap-4 grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+&amp;]:mt-1\" dir=\"auto\" tabindex=\"0\" data-message-author-role=\"assistant\" data-message-id=\"9758953c-ed96-4643-8505-01c2f294210c\" data-turn-start-message=\"true\" data-message-model-slug=\"gpt-5-5\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden\">\n<div class=\"markdown prose dark:prose-invert wrap-break-word w-full light markdown-new-styling\">\n<p data-start=\"78\" data-end=\"449\">India\u2019s IPO market continues to witness strong momentum in 2026, with healthcare and diagnostics companies attracting growing investor interest. Increasing healthcare awareness, rising diagnostic testing volumes, and expansion in pathology and in-vitro diagnostics are creating significant growth opportunities for companies operating in the medical diagnostics sector.<\/p>\n<p data-start=\"451\" data-end=\"657\">Against this backdrop, <strong data-start=\"474\" data-end=\"499\">Q-Line Biotec Limited<\/strong> is set to open its IPO on May 21, 2026. Here is a detailed insight into the company, its IPO, and the industry outlook.<\/p>\n<hr data-start=\"659\" data-end=\"662\" \/>\n<h2 data-section-id=\"1x10m4e\" data-start=\"664\" data-end=\"695\"><span class=\"ez-toc-section\" id=\"About_Q-Line_Biotec_Ltd\"><\/span><span role=\"text\"><strong data-start=\"667\" data-end=\"695\">About Q-Line Biotec Ltd.<\/strong><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p data-start=\"697\" data-end=\"905\">Incorporated in 2010, Q-Line Biotec Limited is engaged in the development, manufacturing, and marketing of a diverse range of diagnostic reagents, consumables, point-of-care devices, and diagnostic equipment.<\/p>\n<p data-start=\"907\" data-end=\"1019\">The company supplies diagnostic equipment and in-vitro diagnostic products directly and through distributors to:<\/p>\n<ul data-start=\"1020\" data-end=\"1087\">\n<li data-section-id=\"14o525c\" data-start=\"1020\" data-end=\"1052\">Diagnostic service providers<\/li>\n<li data-section-id=\"1syksy7\" data-start=\"1053\" data-end=\"1066\">Hospitals<\/li>\n<li data-section-id=\"uhpv3v\" data-start=\"1067\" data-end=\"1087\">Medical colleges<\/li>\n<\/ul>\n<h3 data-section-id=\"mqgjrk\" data-start=\"1089\" data-end=\"1114\"><span class=\"ez-toc-section\" id=\"Business_Segments\"><\/span><span role=\"text\"><strong data-start=\"1093\" data-end=\"1114\">Business Segments<\/strong><\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul data-start=\"1115\" data-end=\"1301\">\n<li data-section-id=\"1m0rrfg\" data-start=\"1115\" data-end=\"1146\">Clinical Chemistry Reagents<\/li>\n<li data-section-id=\"3oyl8z\" data-start=\"1147\" data-end=\"1171\">Haematology Reagents<\/li>\n<li data-section-id=\"sawq0x\" data-start=\"1172\" data-end=\"1193\">Immunodiagnostics<\/li>\n<li data-section-id=\"1wsgmla\" data-start=\"1194\" data-end=\"1219\">Molecular Diagnostics<\/li>\n<li data-section-id=\"1t0pgwj\" data-start=\"1220\" data-end=\"1261\">Point-of-Care Devices and Rapid Tests<\/li>\n<li data-section-id=\"4mhtc6\" data-start=\"1262\" data-end=\"1301\">Pathology Equipment and IVD Devices<\/li>\n<\/ul>\n<p data-start=\"1303\" data-end=\"1327\">As of December 31, 2025:<\/p>\n<ul data-start=\"1328\" data-end=\"1498\">\n<li data-section-id=\"1x7tka8\" data-start=\"1328\" data-end=\"1425\">The company had an annual manufacturing capacity of approximately 1.4 million diagnostic kits<\/li>\n<li data-section-id=\"1luwrd9\" data-start=\"1426\" data-end=\"1498\">It also had capacity to manufacture 1,200 Selectra Machines annually<\/li>\n<\/ul>\n<p data-start=\"1500\" data-end=\"1560\">The company\u2019s manufacturing and operations teams consist of:<\/p>\n<ul data-start=\"1561\" data-end=\"1616\">\n<li data-section-id=\"qbfapi\" data-start=\"1561\" data-end=\"1588\">126 permanent employees<\/li>\n<li data-section-id=\"1p4nhy6\" data-start=\"1589\" data-end=\"1616\">223 third-party workers<\/li>\n<\/ul>\n<h3 data-section-id=\"11tn3vb\" data-start=\"1618\" data-end=\"1647\"><span class=\"ez-toc-section\" id=\"Competitive_Strengths\"><\/span><span role=\"text\"><strong data-start=\"1622\" data-end=\"1647\">Competitive Strengths<\/strong><\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul data-start=\"1648\" data-end=\"1859\">\n<li data-section-id=\"v1xiu\" data-start=\"1648\" data-end=\"1693\">Strong manufacturing and R&amp;D capabilities<\/li>\n<li data-section-id=\"10kle92\" data-start=\"1694\" data-end=\"1738\">Diversified diagnostic product portfolio<\/li>\n<li data-section-id=\"ql9511\" data-start=\"1739\" data-end=\"1773\">Pan-India distribution network<\/li>\n<li data-section-id=\"1arp09c\" data-start=\"1774\" data-end=\"1814\">Long-standing customer relationships<\/li>\n<li data-section-id=\"9tbpq3\" data-start=\"1815\" data-end=\"1859\">Experienced promoter and management team<\/li>\n<\/ul>\n<hr data-start=\"1861\" data-end=\"1864\" \/>\n<h2 data-section-id=\"1lpmunp\" data-start=\"1866\" data-end=\"1898\"><span class=\"ez-toc-section\" id=\"Q-Line_Biotec_IPO_Details\"><\/span><span role=\"text\"><strong data-start=\"1869\" data-end=\"1898\">Q-Line Biotec IPO Details<\/strong><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p data-start=\"1900\" data-end=\"2011\">Q-Line Biotec IPO is a book-building issue aggregating to \u20b9214.48 crore and consists entirely of a fresh issue.<\/p>\n<p data-start=\"2013\" data-end=\"2149\">The company plans to utilise the proceeds towards working capital requirements, repayment of borrowings, and general corporate purposes.<\/p>\n<hr data-start=\"2151\" data-end=\"2154\" \/>\n<h2 data-section-id=\"1ihmiy6\" data-start=\"2156\" data-end=\"2185\"><span class=\"ez-toc-section\" id=\"Important_IPO_Timeline\"><\/span><span role=\"text\"><strong data-start=\"2159\" data-end=\"2185\">Important IPO Timeline<\/strong><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div class=\"TyagGW_tableContainer\">\n<div class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\">\n<table class=\"w-fit min-w-(--thread-content-width)\" data-start=\"2187\" data-end=\"2462\">\n<thead data-start=\"2187\" data-end=\"2203\">\n<tr data-start=\"2187\" data-end=\"2203\">\n<th class=\"last:pe-10\" data-start=\"2187\" data-end=\"2195\" data-col-size=\"sm\">Event<\/th>\n<th class=\"last:pe-10\" data-start=\"2195\" data-end=\"2203\" data-col-size=\"sm\">Date<\/th>\n<\/tr>\n<\/thead>\n<tbody data-start=\"2220\" data-end=\"2462\">\n<tr data-start=\"2220\" data-end=\"2252\">\n<td data-start=\"2220\" data-end=\"2236\" data-col-size=\"sm\">IPO Open Date<\/td>\n<td data-col-size=\"sm\" data-start=\"2236\" data-end=\"2252\">May 21, 2026<\/td>\n<\/tr>\n<tr data-start=\"2253\" data-end=\"2286\">\n<td data-start=\"2253\" data-end=\"2270\" data-col-size=\"sm\">IPO Close Date<\/td>\n<td data-col-size=\"sm\" data-start=\"2270\" data-end=\"2286\">May 25, 2026<\/td>\n<\/tr>\n<tr data-start=\"2287\" data-end=\"2332\">\n<td data-start=\"2287\" data-end=\"2316\" data-col-size=\"sm\">Allotment Date (Tentative)<\/td>\n<td data-start=\"2316\" data-end=\"2332\" data-col-size=\"sm\">May 26, 2026<\/td>\n<\/tr>\n<tr data-start=\"2333\" data-end=\"2373\">\n<td data-start=\"2333\" data-end=\"2357\" data-col-size=\"sm\">Initiation of Refunds<\/td>\n<td data-col-size=\"sm\" data-start=\"2357\" data-end=\"2373\">May 27, 2026<\/td>\n<\/tr>\n<tr data-start=\"2374\" data-end=\"2418\">\n<td data-start=\"2374\" data-end=\"2402\" data-col-size=\"sm\">Credit of Shares to Demat<\/td>\n<td data-start=\"2402\" data-end=\"2418\" data-col-size=\"sm\">May 27, 2026<\/td>\n<\/tr>\n<tr data-start=\"2419\" data-end=\"2462\">\n<td data-start=\"2419\" data-end=\"2446\" data-col-size=\"sm\">Listing Date (Tentative)<\/td>\n<td data-col-size=\"sm\" data-start=\"2446\" data-end=\"2462\">May 29, 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<hr data-start=\"2464\" data-end=\"2467\" \/>\n<h2 data-section-id=\"fcj67a\" data-start=\"2469\" data-end=\"2491\"><span class=\"ez-toc-section\" id=\"Key_IPO_Details\"><\/span><span role=\"text\"><strong data-start=\"2472\" data-end=\"2491\">Key IPO Details<\/strong><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div class=\"TyagGW_tableContainer\">\n<div class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\">\n<table class=\"w-fit min-w-(--thread-content-width)\" data-start=\"2493\" data-end=\"2890\">\n<thead data-start=\"2493\" data-end=\"2518\">\n<tr data-start=\"2493\" data-end=\"2518\">\n<th class=\"last:pe-10\" data-start=\"2493\" data-end=\"2507\" data-col-size=\"sm\">Particulars<\/th>\n<th class=\"last:pe-10\" data-start=\"2507\" data-end=\"2518\" data-col-size=\"sm\">Details<\/th>\n<\/tr>\n<\/thead>\n<tbody data-start=\"2543\" data-end=\"2890\">\n<tr data-start=\"2543\" data-end=\"2573\">\n<td data-start=\"2543\" data-end=\"2556\" data-col-size=\"sm\">Face Value<\/td>\n<td data-col-size=\"sm\" data-start=\"2556\" data-end=\"2573\">\u20b910 per share<\/td>\n<\/tr>\n<tr data-start=\"2574\" data-end=\"2613\">\n<td data-start=\"2574\" data-end=\"2587\" data-col-size=\"sm\">Price Band<\/td>\n<td data-start=\"2587\" data-end=\"2613\" data-col-size=\"sm\">\u20b9326 to \u20b9343 per share<\/td>\n<\/tr>\n<tr data-start=\"2614\" data-end=\"2639\">\n<td data-start=\"2614\" data-end=\"2625\" data-col-size=\"sm\">Lot Size<\/td>\n<td data-col-size=\"sm\" data-start=\"2625\" data-end=\"2639\">400 Shares<\/td>\n<\/tr>\n<tr data-start=\"2640\" data-end=\"2673\">\n<td data-start=\"2640\" data-end=\"2653\" data-col-size=\"sm\">Issue Type<\/td>\n<td data-start=\"2653\" data-end=\"2673\" data-col-size=\"sm\">Bookbuilding IPO<\/td>\n<\/tr>\n<tr data-start=\"2674\" data-end=\"2723\">\n<td data-start=\"2674\" data-end=\"2693\" data-col-size=\"sm\">Total Issue Size<\/td>\n<td data-col-size=\"sm\" data-start=\"2693\" data-end=\"2723\">62,53,200 shares (\u20b9214 Cr)<\/td>\n<\/tr>\n<tr data-start=\"2724\" data-end=\"2768\">\n<td data-start=\"2724\" data-end=\"2738\" data-col-size=\"sm\">Fresh Issue<\/td>\n<td data-col-size=\"sm\" data-start=\"2738\" data-end=\"2768\">59,40,000 shares (\u20b9204 Cr)<\/td>\n<\/tr>\n<tr data-start=\"2769\" data-end=\"2793\">\n<td data-start=\"2769\" data-end=\"2782\" data-col-size=\"sm\">Listing At<\/td>\n<td data-col-size=\"sm\" data-start=\"2782\" data-end=\"2793\">NSE SME<\/td>\n<\/tr>\n<tr data-start=\"2794\" data-end=\"2841\">\n<td data-start=\"2794\" data-end=\"2819\" data-col-size=\"sm\">Shareholding Pre-issue<\/td>\n<td data-start=\"2819\" data-end=\"2841\" data-col-size=\"sm\">1,70,74,999 shares<\/td>\n<\/tr>\n<tr data-start=\"2842\" data-end=\"2890\">\n<td data-start=\"2842\" data-end=\"2868\" data-col-size=\"sm\">Shareholding Post-issue<\/td>\n<td data-col-size=\"sm\" data-start=\"2868\" data-end=\"2890\">2,33,28,199 shares<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<hr data-start=\"2892\" data-end=\"2895\" \/>\n<h2 data-section-id=\"8koabo\" data-start=\"2897\" data-end=\"2921\"><span class=\"ez-toc-section\" id=\"Issue_Reservation\"><\/span><span role=\"text\"><strong data-start=\"2900\" data-end=\"2921\">Issue Reservation<\/strong><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div class=\"TyagGW_tableContainer\">\n<div class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\">\n<table class=\"w-fit min-w-(--thread-content-width)\" data-start=\"2923\" data-end=\"3072\">\n<thead data-start=\"2923\" data-end=\"2952\">\n<tr data-start=\"2923\" data-end=\"2952\">\n<th class=\"last:pe-10\" data-start=\"2923\" data-end=\"2934\" data-col-size=\"sm\">Category<\/th>\n<th class=\"last:pe-10\" data-start=\"2934\" data-end=\"2952\" data-col-size=\"sm\">Shares Offered<\/th>\n<\/tr>\n<\/thead>\n<tbody data-start=\"2982\" data-end=\"3072\">\n<tr data-start=\"2982\" data-end=\"2998\">\n<td data-start=\"2982\" data-end=\"2988\" data-col-size=\"sm\">QIB<\/td>\n<td data-col-size=\"sm\" data-start=\"2988\" data-end=\"2998\">49.99%<\/td>\n<\/tr>\n<tr data-start=\"2999\" data-end=\"3021\">\n<td data-start=\"2999\" data-end=\"3011\" data-col-size=\"sm\">NII (HNI)<\/td>\n<td data-col-size=\"sm\" data-start=\"3011\" data-end=\"3021\">15.01%<\/td>\n<\/tr>\n<tr data-start=\"3022\" data-end=\"3047\">\n<td data-start=\"3022\" data-end=\"3037\" data-col-size=\"sm\">Retail (RII)<\/td>\n<td data-col-size=\"sm\" data-start=\"3037\" data-end=\"3047\">35.00%<\/td>\n<\/tr>\n<tr data-start=\"3048\" data-end=\"3072\">\n<td data-start=\"3048\" data-end=\"3063\" data-col-size=\"sm\">Market Maker<\/td>\n<td data-start=\"3063\" data-end=\"3072\" data-col-size=\"sm\">5.01%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<hr data-start=\"3074\" data-end=\"3077\" \/>\n<h2 data-section-id=\"1gl3oek\" data-start=\"3079\" data-end=\"3115\"><span class=\"ez-toc-section\" id=\"Lot_Size_of_Q-Line_Biotec_IPO\"><\/span><span role=\"text\"><strong data-start=\"3082\" data-end=\"3115\">Lot Size of Q-Line Biotec IPO<\/strong><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div class=\"TyagGW_tableContainer\">\n<div class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\">\n<table class=\"w-fit min-w-(--thread-content-width)\" data-start=\"3117\" data-end=\"3396\">\n<thead data-start=\"3117\" data-end=\"3157\">\n<tr data-start=\"3117\" data-end=\"3157\">\n<th class=\"last:pe-10\" data-start=\"3117\" data-end=\"3131\" data-col-size=\"sm\">Application<\/th>\n<th class=\"last:pe-10\" data-start=\"3131\" data-end=\"3138\" data-col-size=\"sm\">Lots<\/th>\n<th class=\"last:pe-10\" data-start=\"3138\" data-end=\"3147\" data-col-size=\"sm\">Shares<\/th>\n<th class=\"last:pe-10\" data-start=\"3147\" data-end=\"3157\" data-col-size=\"sm\">Amount<\/th>\n<\/tr>\n<\/thead>\n<tbody data-start=\"3198\" data-end=\"3396\">\n<tr data-start=\"3198\" data-end=\"3236\">\n<td data-start=\"3198\" data-end=\"3213\" data-col-size=\"sm\">Retail (Min)<\/td>\n<td data-start=\"3213\" data-end=\"3217\" data-col-size=\"sm\">2<\/td>\n<td data-start=\"3217\" data-end=\"3223\" data-col-size=\"sm\">800<\/td>\n<td data-start=\"3223\" data-end=\"3236\" data-col-size=\"sm\">\u20b92,74,400<\/td>\n<\/tr>\n<tr data-start=\"3237\" data-end=\"3275\">\n<td data-start=\"3237\" data-end=\"3252\" data-col-size=\"sm\">Retail (Max)<\/td>\n<td data-col-size=\"sm\" data-start=\"3252\" data-end=\"3256\">2<\/td>\n<td data-col-size=\"sm\" data-start=\"3256\" data-end=\"3262\">800<\/td>\n<td data-col-size=\"sm\" data-start=\"3262\" data-end=\"3275\">\u20b92,74,400<\/td>\n<\/tr>\n<tr data-start=\"3276\" data-end=\"3315\">\n<td data-start=\"3276\" data-end=\"3290\" data-col-size=\"sm\">S-HNI (Min)<\/td>\n<td data-start=\"3290\" data-end=\"3294\" data-col-size=\"sm\">3<\/td>\n<td data-start=\"3294\" data-end=\"3302\" data-col-size=\"sm\">1,200<\/td>\n<td data-start=\"3302\" data-end=\"3315\" data-col-size=\"sm\">\u20b94,11,600<\/td>\n<\/tr>\n<tr data-start=\"3316\" data-end=\"3355\">\n<td data-start=\"3316\" data-end=\"3330\" data-col-size=\"sm\">S-HNI (Max)<\/td>\n<td data-col-size=\"sm\" data-start=\"3330\" data-end=\"3334\">7<\/td>\n<td data-col-size=\"sm\" data-start=\"3334\" data-end=\"3342\">2,800<\/td>\n<td data-col-size=\"sm\" data-start=\"3342\" data-end=\"3355\">\u20b99,60,400<\/td>\n<\/tr>\n<tr data-start=\"3356\" data-end=\"3396\">\n<td data-start=\"3356\" data-end=\"3370\" data-col-size=\"sm\">B-HNI (Min)<\/td>\n<td data-col-size=\"sm\" data-start=\"3370\" data-end=\"3374\">8<\/td>\n<td data-col-size=\"sm\" data-start=\"3374\" data-end=\"3382\">3,200<\/td>\n<td data-col-size=\"sm\" data-start=\"3382\" data-end=\"3396\">\u20b910,97,600<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<hr data-start=\"3398\" data-end=\"3401\" \/>\n<h2 data-section-id=\"1dfsbd5\" data-start=\"3403\" data-end=\"3439\"><span class=\"ez-toc-section\" id=\"Q-Line_Biotec_Ltd_Financials\"><\/span><span role=\"text\"><strong data-start=\"3406\" data-end=\"3439\">Q-Line Biotec Ltd. Financials<\/strong><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p data-start=\"3441\" data-end=\"3629\">The company has demonstrated consistent growth in revenue and profitability over recent years, supported by increasing demand for diagnostic products and healthcare testing infrastructure.<\/p>\n<h3 data-section-id=\"dt80e5\" data-start=\"3631\" data-end=\"3671\"><span class=\"ez-toc-section\" id=\"Key_Company_Financials_%E2%82%B9_Crore\"><\/span><span role=\"text\"><strong data-start=\"3635\" data-end=\"3671\">Key Company Financials (\u20b9 Crore)<\/strong><\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<div class=\"TyagGW_tableContainer\">\n<div class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\">\n<table class=\"w-fit min-w-(--thread-content-width)\" data-start=\"3673\" data-end=\"4176\">\n<thead data-start=\"3673\" data-end=\"3745\">\n<tr data-start=\"3673\" data-end=\"3745\">\n<th class=\"last:pe-10\" data-start=\"3673\" data-end=\"3688\" data-col-size=\"sm\">Period Ended<\/th>\n<th class=\"last:pe-10\" data-start=\"3688\" data-end=\"3702\" data-col-size=\"sm\">Dec 31 2025<\/th>\n<th class=\"last:pe-10\" data-start=\"3702\" data-end=\"3716\" data-col-size=\"sm\">Mar 31 2025<\/th>\n<th class=\"last:pe-10\" data-start=\"3716\" data-end=\"3730\" data-col-size=\"sm\">Mar 31 2024<\/th>\n<th class=\"last:pe-10\" data-start=\"3730\" data-end=\"3745\" data-col-size=\"sm\">Mar 31 2023<\/th>\n<\/tr>\n<\/thead>\n<tbody data-start=\"3819\" data-end=\"4176\">\n<tr data-start=\"3819\" data-end=\"3865\">\n<td data-start=\"3819\" data-end=\"3828\" data-col-size=\"sm\">Assets<\/td>\n<td data-col-size=\"sm\" data-start=\"3828\" data-end=\"3837\">561.34<\/td>\n<td data-col-size=\"sm\" data-start=\"3837\" data-end=\"3846\">455.49<\/td>\n<td data-col-size=\"sm\" data-start=\"3846\" data-end=\"3855\">339.25<\/td>\n<td data-col-size=\"sm\" data-start=\"3855\" data-end=\"3865\">251.58<\/td>\n<\/tr>\n<tr data-start=\"3866\" data-end=\"3918\">\n<td data-start=\"3866\" data-end=\"3881\" data-col-size=\"sm\">Total Income<\/td>\n<td data-start=\"3881\" data-end=\"3890\" data-col-size=\"sm\">236.50<\/td>\n<td data-col-size=\"sm\" data-start=\"3890\" data-end=\"3899\">322.58<\/td>\n<td data-col-size=\"sm\" data-start=\"3899\" data-end=\"3908\">206.45<\/td>\n<td data-col-size=\"sm\" data-start=\"3908\" data-end=\"3918\">184.81<\/td>\n<\/tr>\n<tr data-start=\"3919\" data-end=\"3971\">\n<td data-start=\"3919\" data-end=\"3938\" data-col-size=\"sm\">Profit After Tax<\/td>\n<td data-col-size=\"sm\" data-start=\"3938\" data-end=\"3946\">38.69<\/td>\n<td data-col-size=\"sm\" data-start=\"3946\" data-end=\"3954\">28.13<\/td>\n<td data-col-size=\"sm\" data-start=\"3954\" data-end=\"3962\">34.44<\/td>\n<td data-col-size=\"sm\" data-start=\"3962\" data-end=\"3971\">32.10<\/td>\n<\/tr>\n<tr data-start=\"3972\" data-end=\"4014\">\n<td data-start=\"3972\" data-end=\"3981\" data-col-size=\"sm\">EBITDA<\/td>\n<td data-col-size=\"sm\" data-start=\"3981\" data-end=\"3989\">64.23<\/td>\n<td data-col-size=\"sm\" data-start=\"3989\" data-end=\"3997\">71.32<\/td>\n<td data-col-size=\"sm\" data-start=\"3997\" data-end=\"4005\">37.63<\/td>\n<td data-col-size=\"sm\" data-start=\"4005\" data-end=\"4014\">32.98<\/td>\n<\/tr>\n<tr data-start=\"4015\" data-end=\"4063\">\n<td data-start=\"4015\" data-end=\"4027\" data-col-size=\"sm\">Net Worth<\/td>\n<td data-col-size=\"sm\" data-start=\"4027\" data-end=\"4035\">-0.04<\/td>\n<td data-col-size=\"sm\" data-start=\"4035\" data-end=\"4044\">189.95<\/td>\n<td data-col-size=\"sm\" data-start=\"4044\" data-end=\"4053\">161.81<\/td>\n<td data-col-size=\"sm\" data-start=\"4053\" data-end=\"4063\">127.37<\/td>\n<\/tr>\n<tr data-start=\"4064\" data-end=\"4122\">\n<td data-start=\"4064\" data-end=\"4087\" data-col-size=\"sm\">Reserves and Surplus<\/td>\n<td data-col-size=\"sm\" data-start=\"4087\" data-end=\"4094\">2.13<\/td>\n<td data-col-size=\"sm\" data-start=\"4094\" data-end=\"4103\">188.37<\/td>\n<td data-col-size=\"sm\" data-start=\"4103\" data-end=\"4112\">160.24<\/td>\n<td data-col-size=\"sm\" data-start=\"4112\" data-end=\"4122\">125.79<\/td>\n<\/tr>\n<tr data-start=\"4123\" data-end=\"4176\">\n<td data-start=\"4123\" data-end=\"4141\" data-col-size=\"sm\">Total Borrowing<\/td>\n<td data-start=\"4141\" data-end=\"4150\" data-col-size=\"sm\">243.85<\/td>\n<td data-start=\"4150\" data-end=\"4159\" data-col-size=\"sm\">164.95<\/td>\n<td data-col-size=\"sm\" data-start=\"4159\" data-end=\"4167\">96.91<\/td>\n<td data-col-size=\"sm\" data-start=\"4167\" data-end=\"4176\">73.65<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<hr data-start=\"4178\" data-end=\"4181\" \/>\n<h2 data-section-id=\"1or2caz\" data-start=\"4183\" data-end=\"4222\"><span class=\"ez-toc-section\" id=\"Key_Performance_Indicators_KPI\"><\/span><span role=\"text\"><strong data-start=\"4186\" data-end=\"4222\">Key Performance Indicators (KPI)<\/strong><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div class=\"TyagGW_tableContainer\">\n<div class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\">\n<table class=\"w-fit min-w-(--thread-content-width)\" data-start=\"4224\" data-end=\"4476\">\n<thead data-start=\"4224\" data-end=\"4259\">\n<tr data-start=\"4224\" data-end=\"4259\">\n<th class=\"last:pe-10\" data-start=\"4224\" data-end=\"4230\" data-col-size=\"sm\">KPI<\/th>\n<th class=\"last:pe-10\" data-start=\"4230\" data-end=\"4244\" data-col-size=\"sm\">Dec 31 2025<\/th>\n<th class=\"last:pe-10\" data-start=\"4244\" data-end=\"4259\" data-col-size=\"sm\">Mar 31 2025<\/th>\n<\/tr>\n<\/thead>\n<tbody data-start=\"4296\" data-end=\"4476\">\n<tr data-start=\"4296\" data-end=\"4321\">\n<td data-start=\"4296\" data-end=\"4302\" data-col-size=\"sm\">ROE<\/td>\n<td data-start=\"4302\" data-end=\"4311\" data-col-size=\"sm\">16.88%<\/td>\n<td data-start=\"4311\" data-end=\"4321\" data-col-size=\"sm\">17.66%<\/td>\n<\/tr>\n<tr data-start=\"4322\" data-end=\"4348\">\n<td data-start=\"4322\" data-end=\"4329\" data-col-size=\"sm\">ROCE<\/td>\n<td data-start=\"4329\" data-end=\"4338\" data-col-size=\"sm\">13.32%<\/td>\n<td data-col-size=\"sm\" data-start=\"4338\" data-end=\"4348\">23.74%<\/td>\n<\/tr>\n<tr data-start=\"4349\" data-end=\"4381\">\n<td data-start=\"4349\" data-end=\"4366\" data-col-size=\"sm\">Debt to Equity<\/td>\n<td data-start=\"4366\" data-end=\"4373\" data-col-size=\"sm\">1.06<\/td>\n<td data-start=\"4373\" data-end=\"4381\" data-col-size=\"sm\">0.87<\/td>\n<\/tr>\n<tr data-start=\"4382\" data-end=\"4408\">\n<td data-start=\"4382\" data-end=\"4389\" data-col-size=\"sm\">RoNW<\/td>\n<td data-start=\"4389\" data-end=\"4398\" data-col-size=\"sm\">16.88%<\/td>\n<td data-start=\"4398\" data-end=\"4408\" data-col-size=\"sm\">23.74%<\/td>\n<\/tr>\n<tr data-start=\"4409\" data-end=\"4440\">\n<td data-start=\"4409\" data-end=\"4422\" data-col-size=\"sm\">PAT Margin<\/td>\n<td data-start=\"4422\" data-end=\"4431\" data-col-size=\"sm\">16.65%<\/td>\n<td data-start=\"4431\" data-end=\"4440\" data-col-size=\"sm\">8.97%<\/td>\n<\/tr>\n<tr data-start=\"4441\" data-end=\"4476\">\n<td data-start=\"4441\" data-end=\"4457\" data-col-size=\"sm\">EBITDA Margin<\/td>\n<td data-start=\"4457\" data-end=\"4466\" data-col-size=\"sm\">27.64%<\/td>\n<td data-col-size=\"sm\" data-start=\"4466\" data-end=\"4476\">22.73%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<hr data-start=\"4478\" data-end=\"4481\" \/>\n<h2 data-section-id=\"11y5vmk\" data-start=\"4483\" data-end=\"4514\"><span class=\"ez-toc-section\" id=\"IPO_Objects_of_the_Issue\"><\/span><span role=\"text\"><strong data-start=\"4486\" data-end=\"4514\">IPO Objects of the Issue<\/strong><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div class=\"TyagGW_tableContainer\">\n<div class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\">\n<table class=\"w-fit min-w-(--thread-content-width)\" data-start=\"4516\" data-end=\"4696\">\n<thead data-start=\"4516\" data-end=\"4543\">\n<tr data-start=\"4516\" data-end=\"4543\">\n<th class=\"last:pe-10\" data-start=\"4516\" data-end=\"4526\" data-col-size=\"sm\">Purpose<\/th>\n<th class=\"last:pe-10\" data-start=\"4526\" data-end=\"4543\" data-col-size=\"sm\">Amount (\u20b9 Cr)<\/th>\n<\/tr>\n<\/thead>\n<tbody data-start=\"4571\" data-end=\"4696\">\n<tr data-start=\"4571\" data-end=\"4619\">\n<td data-start=\"4571\" data-end=\"4610\" data-col-size=\"sm\">Funding working capital requirements<\/td>\n<td data-col-size=\"sm\" data-start=\"4610\" data-end=\"4619\">93.50<\/td>\n<\/tr>\n<tr data-start=\"4620\" data-end=\"4655\">\n<td data-start=\"4620\" data-end=\"4646\" data-col-size=\"sm\">Repayment of borrowings<\/td>\n<td data-col-size=\"sm\" data-start=\"4646\" data-end=\"4655\">90.00<\/td>\n<\/tr>\n<tr data-start=\"4656\" data-end=\"4696\">\n<td data-start=\"4656\" data-end=\"4685\" data-col-size=\"sm\">General corporate purposes<\/td>\n<td data-col-size=\"sm\" data-start=\"4685\" data-end=\"4696\">Balance<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<hr data-start=\"4698\" data-end=\"4701\" \/>\n<h2 data-section-id=\"1fv89qy\" data-start=\"4703\" data-end=\"4746\"><span class=\"ez-toc-section\" id=\"Q-Line_Biotec_Ltd_Industry_Outlook\"><\/span><span role=\"text\"><strong data-start=\"4706\" data-end=\"4746\">Q-Line Biotec Ltd.: Industry Outlook<\/strong><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul data-start=\"4748\" data-end=\"5320\">\n<li data-section-id=\"1ll8zc6\" data-start=\"4748\" data-end=\"4866\">India\u2019s diagnostics and in-vitro diagnostics market is witnessing strong growth due to rising healthcare awareness<\/li>\n<li data-section-id=\"1ygy67w\" data-start=\"4867\" data-end=\"4969\">Increasing demand for pathology testing and preventive healthcare is supporting industry expansion<\/li>\n<li data-section-id=\"14omxce\" data-start=\"4970\" data-end=\"5088\">Growth in hospitals, diagnostic labs, and medical colleges is driving demand for diagnostic equipment and reagents<\/li>\n<li data-section-id=\"m8vqp2\" data-start=\"5089\" data-end=\"5203\">Indigenous manufacturing of diagnostic products is gaining momentum under healthcare self-reliance initiatives<\/li>\n<li data-section-id=\"ls1whq\" data-start=\"5204\" data-end=\"5320\">Technological advancements in molecular diagnostics and rapid testing are expected to drive future sector growth<\/li>\n<\/ul>\n<hr data-start=\"5322\" data-end=\"5325\" \/>\n<h2 data-section-id=\"9dt57q\" data-start=\"5327\" data-end=\"5344\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><span role=\"text\"><strong data-start=\"5330\" data-end=\"5344\">Conclusion<\/strong><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p data-start=\"5346\" data-end=\"5644\">Q-Line Biotec Limited operates in the growing diagnostics and healthcare testing segment with a diversified product portfolio and established manufacturing capabilities. The company benefits from strong distribution networks, increasing healthcare demand, and a broad range of diagnostic solutions.<\/p>\n<p data-start=\"5646\" data-end=\"6000\" data-is-last-node=\"\" data-is-only-node=\"\">However, investors should carefully evaluate risks such as high borrowing levels, competitive industry dynamics, and valuation concerns due to the absence of listed peers. Based on recent financial performance, the IPO appears fully priced and may be suitable for informed investors with a moderate to high risk appetite and long-term investment horizon.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\n<\/div>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_id=&#8221;share_rating&#8221;][vc_column_inner width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<\/p>\n<h6>Rate this article<\/h6>\n<!-- FeedbackWP Plugin --><div  class=\"rmp-widgets-container rmp-wp-plugin rmp-main-container js-rmp-widgets-container js-rmp-widgets-container--16328 \"  data-post-id=\"16328\">    <!-- Rating widget -->  <div class=\"rmp-rating-widget js-rmp-rating-widget\">            <div class=\"rmp-rating-widget__icons\">      <ul class=\"rmp-rating-widget__icons-list js-rmp-rating-icons-list\">                  <li class=\"rmp-rating-widget__icons-list__icon js-rmp-rating-item\" data-descriptive-rating=\"Terrible!\" data-value=\"1\">              <i class=\"js-rmp-rating-icon rmp-icon rmp-icon--ratings rmp-icon--star rmp-icon--full-highlight\"><\/i>          <\/li>                  <li class=\"rmp-rating-widget__icons-list__icon js-rmp-rating-item\" data-descriptive-rating=\"Bad!\" data-value=\"2\">              <i class=\"js-rmp-rating-icon rmp-icon rmp-icon--ratings rmp-icon--star rmp-icon--full-highlight\"><\/i>          <\/li>                  <li class=\"rmp-rating-widget__icons-list__icon js-rmp-rating-item\" data-descriptive-rating=\"Okay!\" data-value=\"3\">              <i class=\"js-rmp-rating-icon rmp-icon rmp-icon--ratings rmp-icon--star rmp-icon--full-highlight\"><\/i>          <\/li>                  <li class=\"rmp-rating-widget__icons-list__icon js-rmp-rating-item\" data-descriptive-rating=\"Good!\" data-value=\"4\">              <i class=\"js-rmp-rating-icon rmp-icon rmp-icon--ratings rmp-icon--star rmp-icon--full-highlight\"><\/i>          <\/li>                  <li class=\"rmp-rating-widget__icons-list__icon js-rmp-rating-item\" data-descriptive-rating=\"Great!\" data-value=\"5\">              <i class=\"js-rmp-rating-icon rmp-icon rmp-icon--ratings rmp-icon--star rmp-icon--half-highlight js-rmp-remove-half-star\"><\/i>          <\/li>              <\/ul>    <\/div>    <p class=\"rmp-rating-widget__hover-text js-rmp-hover-text\"><\/p>    <button class=\"rmp-rating-widget__submit-btn rmp-btn js-submit-rating-btn\">      Submit Rating    <\/button>    <p class=\"rmp-rating-widget__results js-rmp-results \">       <span class=\"rmp-rating-widget__results__rating js-rmp-avg-rating\">4.3<\/span> \/ 5.  <span class=\"rmp-rating-widget__results__votes js-rmp-vote-count\">12<\/span>    <\/p>    <p class=\"rmp-rating-widget__not-rated js-rmp-not-rated rmp-rating-widget__not-rated--hidden\">          <\/p>    <p class=\"rmp-rating-widget__msg js-rmp-msg\"><\/p>  <\/div>  <!--Structured data -->        <\/div>\n<div id=\"emoji-overlay\" style=\"display: none;\">\n<div id=\"overlay-emoji\"><\/div>\n<div id=\"overlay-description\" class=\"emoji-text\"><\/div>\n<\/div>\n<div id=\"rating-popup\">\n<p><span id=\"popup-close\">\u00d7<\/span><\/p>\n<div class=\"popup_message\">\n<div id=\"popup-emoji\"><\/div>\n<div class=\"popup_innermsg\">\n<h5>Thank You for Rating Our Article!<\/h5>\n<p>Your feedback is incredibly valuable to us, and we&#8217;re thrilled to hear your thoughts.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<\/p>\n<h6>Share this article<\/h6>\n<div class=\"cscra-social square cscra-socials-679c8a1122c00\">\n        <a href=\"\/\/www.facebook.com\/sharer\/sharer.php?u=https%3A%2F%2Fwww.torusdigital.com%2Ftoruscope%2Fnews%2Fq-line-biotech-ipo-opens-key-details-investors-shouldnt-miss%2F&t=Q-Line+Biotech+IPO+Opens%3A+Key+Details+Investors+Shouldn%E2%80%99t+Miss\" class=\"facebook\" data-toggle=\"tooltip\" data-placement=\"top\" title=\"Share On Facebook\" target=\"_blank\"><i class=\"fa fa-facebook\"><\/i><\/a>\n        <a href=\"\/\/twitter.com\/intent\/tweet?text=Q-Line+Biotech+IPO+Opens%3A+Key+Details+Investors+Shouldn%E2%80%99t+Miss&url=https%3A%2F%2Fwww.torusdigital.com%2Ftoruscope%2Fnews%2Fq-line-biotech-ipo-opens-key-details-investors-shouldnt-miss%2F\" class=\"twitter\" data-toggle=\"tooltip\" data-placement=\"top\" title=\"Share On Twitter\" target=\"_blank\"><i class=\"fa-brands fa-x-twitter\"><\/i><\/a>\n        <a href=\"https:\/\/api.whatsapp.com\/send?text=Q-Line+Biotech+IPO+Opens%3A+Key+Details+Investors+Shouldn%E2%80%99t+Miss - https%3A%2F%2Fwww.torusdigital.com%2Ftoruscope%2Fnews%2Fq-line-biotech-ipo-opens-key-details-investors-shouldnt-miss%2F\" class=\"whatsapp\" data-toggle=\"tooltip\" data-placement=\"top\" title=\"Share On WhatsApp\" target=\"_blank\"><i class=\"fa fa-whatsapp\"><\/i><\/a>\n        <a href=\"\/\/www.linkedin.com\/shareArticle?mini=true&url=https%3A%2F%2Fwww.torusdigital.com%2Ftoruscope%2Fnews%2Fq-line-biotech-ipo-opens-key-details-investors-shouldnt-miss%2F&title=Q-Line+Biotech+IPO+Opens%3A+Key+Details+Investors+Shouldn%E2%80%99t+Miss\" class=\"linkedin\" data-toggle=\"tooltip\" data-placement=\"top\" title=\"Share On Linkedin\" target=\"_blank\"><i class=\"fa fa-linkedin\"><\/i><\/a>\n    <\/div>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][\/vc_section]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"[vc_section el_id=&#8221;blog-inner-layout&#8221;][vc_row overlay_dotted=&#8221;&#8221;][vc_column el_class=&#8221;blog_primary&#8221;][vc_row_inner][vc_column_inner][vc_column_text css=&#8221;&#8221;] India\u2019s IPO market continues to witness strong momentum in 2026, with healthcare and diagnostics companies attracting growing investor interest. Increasing healthcare awareness, rising diagnostic testing volumes, and expansion in pathology and in-vitro diagnostics are creating significant growth opportunities for companies operating in the medical diagnostics sector. Against this backdrop, Q-Line","protected":false},"author":1,"featured_media":14024,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_sitemap_exclude":false,"_sitemap_priority":"","_sitemap_frequency":"","footnotes":""},"categories":[5,169],"tags":[],"class_list":["post-16328","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Q-Line Biotec IPO Opens: Price Band, Details and Review<\/title>\n<meta name=\"description\" content=\"Q-Line Biotec IPO offers exposure to the diagnostics and in-vitro healthcare testing sector. Check IPO dates, price band, lot size, financials, and review before investing.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.torusdigital.com\/toruscope\/news\/q-line-biotech-ipo-opens-key-details-investors-shouldnt-miss\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Q-Line Biotec IPO Opens: Price Band, Details and Review\" \/>\n<meta property=\"og:description\" content=\"Q-Line Biotec IPO offers exposure to the diagnostics and in-vitro healthcare testing sector. Check IPO dates, price band, lot size, financials, and review before investing.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.torusdigital.com\/toruscope\/news\/q-line-biotech-ipo-opens-key-details-investors-shouldnt-miss\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-21T06:44:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-21T06:45:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/08\/Essex-Marine-Ltd-IPO-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1441\" \/>\n\t<meta property=\"og:image:height\" content=\"466\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"torus\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"torus\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Q-Line Biotec IPO Opens: Price Band, Details and Review","description":"Q-Line Biotec IPO offers exposure to the diagnostics and in-vitro healthcare testing sector. Check IPO dates, price band, lot size, financials, and review before investing.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.torusdigital.com\/toruscope\/news\/q-line-biotech-ipo-opens-key-details-investors-shouldnt-miss\/","og_locale":"en_US","og_type":"article","og_title":"Q-Line Biotec IPO Opens: Price Band, Details and Review","og_description":"Q-Line Biotec IPO offers exposure to the diagnostics and in-vitro healthcare testing sector. Check IPO dates, price band, lot size, financials, and review before investing.","og_url":"https:\/\/www.torusdigital.com\/toruscope\/news\/q-line-biotech-ipo-opens-key-details-investors-shouldnt-miss\/","og_site_name":"Blog","article_published_time":"2026-05-21T06:44:35+00:00","article_modified_time":"2026-05-21T06:45:27+00:00","og_image":[{"width":1441,"height":466,"url":"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/08\/Essex-Marine-Ltd-IPO-1.webp","type":"image\/webp"}],"author":"torus","twitter_card":"summary_large_image","twitter_misc":{"Written by":"torus","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/q-line-biotech-ipo-opens-key-details-investors-shouldnt-miss\/","url":"https:\/\/www.torusdigital.com\/toruscope\/news\/q-line-biotech-ipo-opens-key-details-investors-shouldnt-miss\/","name":"Q-Line Biotec IPO Opens: Price Band, Details and Review","isPartOf":{"@id":"https:\/\/www.torusdigital.com\/toruscope\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/q-line-biotech-ipo-opens-key-details-investors-shouldnt-miss\/#primaryimage"},"image":{"@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/q-line-biotech-ipo-opens-key-details-investors-shouldnt-miss\/#primaryimage"},"thumbnailUrl":"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/08\/Essex-Marine-Ltd-IPO-1.webp","datePublished":"2026-05-21T06:44:35+00:00","dateModified":"2026-05-21T06:45:27+00:00","author":{"@id":"https:\/\/www.torusdigital.com\/toruscope\/#\/schema\/person\/468d817c6d51cdd85d58071858a47ce5"},"description":"Q-Line Biotec IPO offers exposure to the diagnostics and in-vitro healthcare testing sector. Check IPO dates, price band, lot size, financials, and review before investing.","breadcrumb":{"@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/q-line-biotech-ipo-opens-key-details-investors-shouldnt-miss\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.torusdigital.com\/toruscope\/news\/q-line-biotech-ipo-opens-key-details-investors-shouldnt-miss\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/q-line-biotech-ipo-opens-key-details-investors-shouldnt-miss\/#primaryimage","url":"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/08\/Essex-Marine-Ltd-IPO-1.webp","contentUrl":"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/08\/Essex-Marine-Ltd-IPO-1.webp","width":1441,"height":466},{"@type":"BreadcrumbList","@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/q-line-biotech-ipo-opens-key-details-investors-shouldnt-miss\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Toruscope","item":"https:\/\/www.torusdigital.com\/toruscope\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.torusdigital.com\/toruscope\/.\/news\/"},{"@type":"ListItem","position":3,"name":"Q-Line Biotech IPO Opens: Key Details Investors Shouldn\u2019t Miss"}]},{"@type":"WebSite","@id":"https:\/\/www.torusdigital.com\/toruscope\/#website","url":"https:\/\/www.torusdigital.com\/toruscope\/","name":"Blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.torusdigital.com\/toruscope\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.torusdigital.com\/toruscope\/#\/schema\/person\/468d817c6d51cdd85d58071858a47ce5","name":"torus","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.torusdigital.com\/toruscope\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/09645f2c6ef6bbb3a78db22600040d547bed4438a393e0671d168d69d193bc19?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/09645f2c6ef6bbb3a78db22600040d547bed4438a393e0671d168d69d193bc19?s=96&d=mm&r=g","caption":"torus"},"sameAs":["https:\/\/stage.torusdigital.com\/blogs"],"url":"https:\/\/www.torusdigital.com\/toruscope\/author\/torus\/"}]}},"_links":{"self":[{"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/posts\/16328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/comments?post=16328"}],"version-history":[{"count":1,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/posts\/16328\/revisions"}],"predecessor-version":[{"id":16329,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/posts\/16328\/revisions\/16329"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/media\/14024"}],"wp:attachment":[{"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/media?parent=16328"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/categories?post=16328"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/tags?post=16328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}